• Contact Us
Pharmaceuticals & Life Sciences Blogs - VWV

Pharma & Life Sciences

Articles & Blogs Pharma & Life Sciences

Hope for Pharma in UK with new VPAG pricing scheme agreed

Thursday, 14 December 2023

The UK pricing scheme for pharma has been a major source of concern, mainly over the pricing mechanism and rebate scheme. This saw a rise in the rebate pharma has had to pay to 26.5% in 2023, but a new deal has now been announced.

Hope for Pharma in UK with new VPAG pricing scheme agreed

Articles & Blogs Pharma & Life Sciences

UK Government announces £100 Million fund for AI in life sciences and healthcare

Thursday, 14 December 2023

The UK Government has launched a new scheme to support the application of AI in life sciences and healthcare, with a £100 million fund to focus on areas where AI is hoped to make a difference in curing previously incurable diseases.

UK Government announces £100 Million fund for AI in life sciences and healthcare

Articles & Blogs Pharma & Life Sciences

AI generating copyright controversy

Thursday, 14 December 2023

One of the big questions concerning the use of AI relates to copyright. Both training and using an AI system might involve unlawful copying or publication of copyright works.

AI generating copyright controversy

Articles & Blogs Pharma & Life Sciences

Court decision shows benefits of negotiating to uphold liability clause

Thursday, 14 December 2023

A recent High Court decision has shown how a party may actually be better off by agreeing to negotiate its contracts.

Court decision shows benefits of negotiating to uphold liability clause

Articles & Blogs Pharma & Life Sciences

UK bodies team up to launch £30m fund to tackle anti-microbial resistance

Friday, 17 November 2023

Innovate UK, LifeArc and the Medicines Discovery Catapult have come together to create a £30m fund to seek to tackle antimicrobial resistance (AMR).

UK bodies team up to launch £30m fund to tackle anti-microbial resistance

Articles & Blogs Pharma & Life Sciences

The Bletchley Declaration - what does it mean for AI in Pharma?

Thursday, 16 November 2023

Artificial Intelligence (AI) is the buzz phrase of the year in the UK and beyond. After the UK held an AI Safety Summit in November, the countries participating signed up to the Bletchley Declaration. But what does it mean for pharma?

The Bletchley Declaration - what does it mean for AI in Pharma?

Articles & Blogs Pharma & Life Sciences

The start of the overhaul - low-risk UK clinical trial approvals made quicker

Thursday, 16 November 2023

The MHRA's guidance on clinical trial applications was updated in October. The guidance refers to a new notification scheme, which was the subject of an MHRA press release dated 12 October 2023.

The start of the overhaul - low-risk UK clinical trial approvals made quicker

Articles & Blogs Pharma & Life Sciences

Marketing authorisation - International Recognition Procedure confirmed

Thursday, 16 November 2023

From next year, organisations holding marketing authorisations (MA) in an approved list of countries can benefit from a new 'International Recognition Procedure' to gain access to the UK market.

Marketing authorisation - International Recognition Procedure confirmed

Articles & Blogs Pharma & Life Sciences

The future of expedited access to innovative medical devices - IDAP clearing the path for eight lucky applicants

Tuesday, 17 October 2023

How do medical devices get on the market quickly? There are lots of (usually long) answers to this question, but one significant new route will be via the Innovative Devices Access Pathway (IDAP).

The future of expedited access to innovative medical devices - IDAP clearing the path for eight lucky applicants

Articles & Blogs Pharma & Life Sciences

The lawyer's role in the future of UK clinical research - What would Lord O'Shaughnessy say?

Friday, 22 September 2023

Following last year's review from Lord O'Shaughnessy on the UK commercial clinical trial landscape, all of us (including lawyers) need to reflect on how to solve the issues flagged in the report.

The lawyer's role in the future of UK clinical research - What would Lord O'Shaughnessy say?

Articles & Blogs Pharma & Life Sciences

Planning consent granted for Europe's most technologically advanced life sciences building at Canary Wharf

Thursday, 21 September 2023

Canary Wharf is rapidly developing to accommodate the Life Sciences Sector - planning consent granted by Tower Hamlets Council for a unique 23-strorey vertical campus encourages an ecosystem within this industry to flourish.

Planning consent granted for Europe's most technologically advanced life sciences building at Canary Wharf

Articles & Blogs Pharma & Life Sciences

Stevenage approves one of Europe's biggest life sciences campuses

Wednesday, 20 September 2023

Stevenage Council has approved one of Europe’s largest Life Science campuses - £900m life science campus with 1.6 million square foot of lab, office and Good Manufacturing Practices (GMP) facilities, and creating 5,000 jobs.

Stevenage approves one of Europe's biggest life sciences campuses

Articles & Blogs Pharma & Life Sciences

How to Navigate the UK's Medtech Sector - Key Developments to Watch

Tuesday, 15 August 2023

As the UK medtech strategy acknowledges multiple times, the sector is complex. Here are a few key developments to be aware of.

How to Navigate the UK's Medtech Sector - Key Developments to Watch

Articles & Blogs Pharma & Life Sciences

Crick Director Warns UK Has to Join EU Horizon Programme

Monday, 07 August 2023

The UK must be part of the EU's Horizon programme if it wants to achieve its ambition of being a 'science superpower'. That is the warning of Sir Paul Nurse, director at the Francis Crick Institute.

Crick Director Warns UK Has to Join EU Horizon Programme

Articles & Blogs Pharma & Life Sciences

The UK's New Medtech Strategy, Explained

Monday, 31 July 2023

Medical device businesses face a whirlwind of change covering the EU and UK. Commercialising medical devices in these regions means navigating multifaceted challenges, legal and beyond. Here's our overview of what you need to know.

The UK's New Medtech  Strategy, Explained